



Dr. Erickson provides an update on the latest FDA block on NIH funded and NIH vetted single dose medication research in fragile X syndrome.

This week Dr. Erickson discussed our announcement of new work showing that about 1 in 4 people on the autism spectrum exhibit brain electrical patterns that we typically see in males with fragile X. Dr. Erickson discusses how this information is being used to design a clinical trial that will enroll both adult men with fragile X and people with autism who do not have fragile X.
Spinogenix Announces Phase 2b Trial for Autism Using Novel Brain-Wave Screening to Target Treatment

The Cincinnati Fragile X Research and Treatment Center is excited to welcome back Austin Corsmeier who is joining us as our Program Manager at the end of 2026. We are super excited about the future working together with Austin again.

We look forward to the opportunity to recruit infants and toddlers with fragile X syndrome from around the USA and the World to participate in this meaningful cutting-edge research.

This week Dr. Erickson introduces our new post doctoral psychologists Dee and Roz!


































January 29, 2026
Join probably 12-20 members of the Cincinnati Fragile X Research and Treatment Center at the Conference, we will be doing research at the conference and our Cincinnati Center is only 90 minutes (100 miles) away from the conference if you want to combine the Conference with a visit to us.

January 23, 2026
This week's update describes research in people with fragile X ongoing at the Cincinnati Fragile X Center














This week Dr. Erickson provides comments that are his own and not intended to reflect the policy, stance, or opinion of Cincinnati Children's Hospital or any other entity.









